1. Home
  2. LEGN vs CVLT Comparison

LEGN vs CVLT Comparison

Compare LEGN & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • CVLT
  • Stock Information
  • Founded
  • LEGN 2014
  • CVLT 1996
  • Country
  • LEGN United States
  • CVLT United States
  • Employees
  • LEGN N/A
  • CVLT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • CVLT Computer Software: Prepackaged Software
  • Sector
  • LEGN Health Care
  • CVLT Technology
  • Exchange
  • LEGN Nasdaq
  • CVLT Nasdaq
  • Market Cap
  • LEGN 7.0B
  • CVLT 7.0B
  • IPO Year
  • LEGN 2020
  • CVLT 2006
  • Fundamental
  • Price
  • LEGN $33.91
  • CVLT $159.10
  • Analyst Decision
  • LEGN Strong Buy
  • CVLT Buy
  • Analyst Count
  • LEGN 13
  • CVLT 10
  • Target Price
  • LEGN $79.17
  • CVLT $160.75
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • CVLT 436.0K
  • Earning Date
  • LEGN 03-11-2025
  • CVLT 04-29-2025
  • Dividend Yield
  • LEGN N/A
  • CVLT N/A
  • EPS Growth
  • LEGN N/A
  • CVLT N/A
  • EPS
  • LEGN N/A
  • CVLT 3.79
  • Revenue
  • LEGN $627,241,000.00
  • CVLT $943,872,000.00
  • Revenue This Year
  • LEGN $66.60
  • CVLT $19.51
  • Revenue Next Year
  • LEGN $49.28
  • CVLT $12.36
  • P/E Ratio
  • LEGN N/A
  • CVLT $42.70
  • Revenue Growth
  • LEGN 119.97
  • CVLT 15.19
  • 52 Week Low
  • LEGN $30.17
  • CVLT $93.48
  • 52 Week High
  • LEGN $60.87
  • CVLT $190.11
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 39.53
  • CVLT 45.28
  • Support Level
  • LEGN $34.00
  • CVLT $159.38
  • Resistance Level
  • LEGN $36.20
  • CVLT $174.58
  • Average True Range (ATR)
  • LEGN 1.39
  • CVLT 5.92
  • MACD
  • LEGN -0.33
  • CVLT 0.42
  • Stochastic Oscillator
  • LEGN 17.81
  • CVLT 42.65

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.

Share on Social Networks: